Robert Driscoll

Stock Analyst at Wedbush

(0)
# 4690
Out of 5,327 analysts
202
Total ratings
21.64%
Success rate
-20.51%
Average return
Main Sectors:
Top Industries:
39 Stocks
Name Action PT Current % Upside Ratings Updated
RVMD Revolution Medicines
Reiterates: Outperform
67 67
40.67 64.74% 5 Apr 28, 2025
ZNTL Zentalis Pharma
Reiterates: Neutral
4 4
1.38 189.86% 10 Mar 28, 2025
GLUE Monte Rosa Therapeut...
Maintains: Outperform
15 17
4.79 254.91% 4 Mar 21, 2025
HOWL Werewolf Therapeutic...
Reiterates: Outperform
8 8
0.84 852.38% 2 Mar 12, 2025
ARVN Arvinas
Downgrades: Neutral
57 12
n/a n/a 9 Mar 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
32 32
7.67 317.21% 6 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
34 36
6.51 453% 8 Feb 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
52 52
19.72 163.69% 9 Dec 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
28 28
10.28 172.37% 8 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
16 16
1.6 900% 10 Oct 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
30 30
8.12 269.46% 7 Oct 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 22
1.31 1579.39% 10 Oct 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 51
n/a n/a 1 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
5 5
0.63 693.65% 8 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
36 36
7.89 356.27% 4 Sep 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
11 11
1.66 562.65% 3 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
13 13
4.24 206.6% 7 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
11 13
1.36 855.88% 4 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
74 74
32.55 127.34% 7 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
12 12
n/a n/a 4 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
8 8
1.83 337.16% 3 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
7 7
1.39 403.6% 8 Jun 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
65
n/a n/a 8 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
3 8
0.66 1112.12% 9 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
8 8
0.35 2185.71% 7 May 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
52
9.39 453.78% 5 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
4 1
n/a n/a 4 Aug 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jun 20, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
3
n/a n/a 3 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
25 36
n/a n/a 2 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
50 70
n/a n/a 4 May 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
9 2
n/a n/a 2 Mar 8, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
136 17
n/a n/a 3 Mar 19, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
5 9
n/a n/a 6 Jun 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
2 4
3.4 17.65% 4 May 19, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
1500 250
n/a n/a 1 Mar 19, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
17 3
n/a n/a 3 Nov 12, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
30 34
n/a n/a 1 Apr 4, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
120 160
n/a n/a 1 Feb 22, 2017